Overview
The sucrose lysis test is a screening laboratory test used for the detection of paroxysmal nocturnal hemoglobinuria. It assesses the sensitivity of red blood cells to complement-mediated lysis in a low ionic strength sucrose medium. In this environment, complement binds more readily to red cells that lack protective surface proteins, leading to hemolysis. The test is historically important and helps identify increased complement sensitivity of red blood cells, though it has largely been replaced by flow cytometry in modern practice.
Symptoms
Patients undergoing evaluation with the sucrose lysis test often present with symptoms suggestive of hemolysis. These include dark-colored urine, especially in the morning, fatigue, shortness of breath, pallor, back pain, abdominal pain, headache, dizziness, and recurrent infections. Increased tendency for venous thrombosis, liver disease, gallstones, and unexplained anemia may also be associated with conditions where the test is indicated.
Causes
A positive sucrose lysis test occurs due to increased susceptibility of red blood cells to complement-mediated destruction. This is most commonly seen in paroxysmal nocturnal hemoglobinuria, where red cells lack complement-regulatory proteins such as CD55 and CD59. Similar hemolysis may occasionally be seen in hypoplastic anemia, hemolytic anemia, and rarely in megaloblastic anemia, leading to suspicious or borderline results. Complement activation in low ionic strength conditions is the fundamental mechanism behind red cell lysis in this test.
Risk Factors
Risk factors associated with abnormal sucrose lysis test results include underlying bone marrow disorders, unexplained hemolytic anemia, recurrent venous thrombosis, and prior episodes of dark urine. Patients with aplastic anemia, leukemia, or autoimmune hemolytic anemia may show false-positive results. Recent blood transfusions and improper sample handling can also influence test outcomes.
Prevention
There is no specific prevention for conditions detected by the sucrose lysis test, but early identification of paroxysmal nocturnal hemoglobinuria helps prevent serious complications such as severe hemolysis and thrombosis. Proper sample collection, prompt testing, and adherence to procedural precautions improve test reliability. Confirmatory testing with flow cytometry is recommended for accurate diagnosis and long-term monitoring. Early diagnosis and appropriate clinical management reduce morbidity and improve patient outcomes.
